Literature DB >> 6860802

A new family with classical factor X deficiency as demonstrated by electroimmunoassay.

A Girolami, G Luzzatto, N Scattolo, F A Zanolli.   

Abstract

A new family with classical factor X deficiency is described. The proposita is a 6 year old girl who presented with occasional epistaxis and a hematoma after an intramuscular injection. The main laboratory features consisted in a prolongation of partial thromboplastin, prothrombin and Stypven clotting times corrected by the addition of normal serum. Factor X activity varied between 3 and 6%. Factor X amydolytic activity was 15% of normal. Electroimmunoassay failed to show the presence of factor X antigen. No inhibitor was found in the proposita plasma. Parents and other family members showed intermediate levels of factor X activity and antigen and were considered to be heterozygotes. No consanguineity was found in the family.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6860802     DOI: 10.1007/bf00321050

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  18 in total

1.  Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.

Authors:  C HOUGIE; E M BARROW; J B GRAHAM
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

2.  [A new congenital coagulation defect; Stuart factor defect].

Authors:  F BACHMANN; F DUCKERT; P FLUCKIGER; W HITZIG; F KOLLER
Journal:  Thromb Diath Haemorrh       Date:  1958-04-15

3.  A new coagulation defect.

Authors:  T P TELFER; K W DENSON; D R WRIGHT
Journal:  Br J Haematol       Date:  1956-07       Impact factor: 6.998

4.  A new sensitive and highly specific chromogenic peptide substrate for factor Xa.

Authors:  L Aurell; P Friberger; G Karlsson; G Claeson
Journal:  Thromb Res       Date:  1977-11       Impact factor: 3.944

5.  Factor X level in coumarin treated patients and in factor X deficiency as assayed with different techniques.

Authors:  A Girolami; A Brunetti; G Bareggi
Journal:  Blut       Date:  1972-08

6.  The activation of factor X evaluated by using synthetic substrates.

Authors:  H Suomela; M Blombäck; B Blombäck
Journal:  Thromb Res       Date:  1977-02       Impact factor: 3.944

7.  Further studies on the abnormal factor X (factor X Friuli) coagulation disorder: a report of another family.

Authors:  A Girolami; M Lazzarin; R Scarpa; A Brunetti
Journal:  Blood       Date:  1971-05       Impact factor: 22.113

8.  Classical factor X deficiency. Report of a further case.

Authors:  A Girolami; P Coser; A Brunetti; O Prinoth
Journal:  Acta Haematol       Date:  1975       Impact factor: 2.195

9.  Factor X assays using chromogenic substrate S-2222.

Authors:  A Girolami; L Saggin; G Boeri
Journal:  Am J Clin Pathol       Date:  1980-03       Impact factor: 2.493

10.  Factor VII Padua defect: the heterozygote population.

Authors:  A Girolami; R Dal Bo Zanon; F Zanella; M Procidano; G Ruffato
Journal:  Acta Haematol       Date:  1982       Impact factor: 2.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.